Moreover, we assessed the correlation between CHPF expression and the survival time in patients with BRCA, and found that patients with high expression of CHPF exhibited a poorer overall survival, DFS, DSS and PFS, which is in agreement with a previous study reporting that elevated CHPF expression resulted in a worse overall survival in lung cancer patients [25]. The gene discussed is CHPF; the disease is lung cancer.